North America Gene Synthesis Market By Method (Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis), By Service Type (Antibody DNA Synthesis, Viral DNA Synthesis and Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
The North America Gene Synthesis Market would witness market growth of 17.7% CAGR during the forecast period (2021-2027).
Gene synthesis is a technique that is included in synthetic biology which is being utilized with the purpose of developing artificial genes while incorporating with laboratory standards. It is widely being used for the production of fusion proteins, cloning molecules, or with the purpose to attain higher protein expression.
The number of people that are adopting gene therapy has increased the number of equipment that are required to perform gene therapy. Also, the treatment of infectious diseases requires advanced and special gene therapy equipment to offer impeccable and flawless gene sequences in a reduced time period to offer absolutely enhanced therapy outcomes which would improve the development of gene synthesis therapy further.
According to the National Institute of Health (NIH) of the United States, synthetic biology is considered as a method for the faster development of various vaccines and to cure distinct genetic disorders. Hence, these factors are anticipated to fuel the growth of the gene synthesis market in the region during the forecasting period.
The US market dominated the North America Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,515.1 million by 2027. The Canada market is expected to witness a CAGR of 20.4% during (2021 - 2027). Additionally, The Mexico market would experience a CAGR of 19.4% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Scope of the Study
Market Segments covered in the Report:
By Method
- Solid-phase Synthesis
- Chip-based Synthesis and
- PCR-based Enzyme Synthesis
- Antibody DNA Synthesis
- Viral DNA Synthesis and
- Others
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis and
- Others
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies and
- Contract Research Organizations
- US
- Canada
- Mexico
- Rest of North America
- Genscript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- Brooks Automation, Inc.
- Boster Biological Technology
- Twist Bioscience Corporation
- Danaher Corporation
- Biomatik Corporation
- ProteoGenix
- ProMab Biotechnologies, Inc.
- OriGene Technologies, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Gene Synthesis Market, by Method
- 1.4.2 North America Gene Synthesis Market, by Service Type
- 1.4.3 North America Gene Synthesis Market, by Application
- 1.4.4 North America Gene Synthesis Market, by End User
- 1.4.5 North America Gene Synthesis Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Acquisition and Mergers
- 3.2.2 Partnerships, Collaborations and Agreements
- 3.2.3 Product Launches and Product Expansions
- 3.2.4 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec – 2021, Nov) Leading Players
- 3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul – 2021, Aug) Leading Players
- Chapter 4. North America Gene Synthesis Market by Method
- 4.1 North America Solid-phase Synthesis Market by Country
- 4.2 North America Chip-based Synthesis Market by Country
- 4.3 North America PCR-based Enzyme Synthesis Market by Country
- Chapter 5. North America Gene Synthesis Market by Service Type
- 5.1 North America Antibody DNA Synthesis Market by Country
- 5.2 North America Viral DNA Synthesis Market by Country
- 5.3 North America Others Market by Country
- Chapter 6. North America Gene Synthesis Market by Application
- 6.1 North America Gene & Cell Therapy Development Market by Country
- 6.2 North America Vaccine Development Market by Country
- 6.3 North America Disease Diagnosis Market by Country
- 6.4 North America Others Market by Country
- Chapter 7. North America Gene Synthesis Market by End User
- 7.1 North America Academic & Government Research Institutes Market by Country
- 7.2 North America Biotechnology & Pharmaceutical Companies Market by Country
- 7.3 North America Contract Research Organizations Market by Country
- Chapter 8. North America Gene Synthesis Market by Country
- 8.1 US Gene Synthesis Market
- 8.1.1 US Gene Synthesis Market by Method
- 8.1.2 US Gene Synthesis Market by Service Type
- 8.1.3 US Gene Synthesis Market by Application
- 8.1.4 US Gene Synthesis Market by End User
- 8.2 Canada Gene Synthesis Market
- 8.2.1 Canada Gene Synthesis Market by Method
- 8.2.2 Canada Gene Synthesis Market by Service Type
- 8.2.3 Canada Gene Synthesis Market by Application
- 8.2.4 Canada Gene Synthesis Market by End User
- 8.3 Mexico Gene Synthesis Market
- 8.3.1 Mexico Gene Synthesis Market by Method
- 8.3.2 Mexico Gene Synthesis Market by Service Type
- 8.3.3 Mexico Gene Synthesis Market by Application
- 8.3.4 Mexico Gene Synthesis Market by End User
- 8.4 Rest of North America Gene Synthesis Market
- 8.4.1 Rest of North America Gene Synthesis Market by Method
- 8.4.2 Rest of North America Gene Synthesis Market by Service Type
- 8.4.3 Rest of North America Gene Synthesis Market by Application
- 8.4.4 Rest of North America Gene Synthesis Market by End User
- Chapter 9. Company Profiles
- 9.1 Genscript Biotech Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional & Segmental Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Product Launches and Product Expansions:
- 9.1.5.3 Acquisition and Mergers:
- 9.1.5.4 Geographical Expansions:
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Acquisition and Mergers:
- 9.2.5.3 Geographical Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Brooks Automation, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional & Segmental Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Acquisition and Mergers:
- 9.4 Boster Biological Technology
- 9.4.1 Company Overview
- 9.5 Twist Bioscience Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional & Segmental Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Acquisition and Mergers:
- 9.5.5.3 Product Launches and Product Expansions:
- 9.5.5.4 Geographical Expansions:
- 9.6 Danaher Corporation
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Product Launches and Product Expansions:
- 9.6.5.2 Acquisition and Mergers:
- 9.6.5.3 Geographical Expansions:
- 9.7 Biomatik Corporation
- 9.7.1 Company Overview
- 9.8 ProteoGenix
- 9.8.1 Company Overview
- 9.9 ProMab Biotechnologies, Inc.
- 9.9.1 Company Overview
- 9.10. OriGene Technologies, Inc.
- 9.10.1 Company Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook